N-(5-chloro-2-propoxybenzyl)-N-(4-(prop-2-yn-1-ylsulfonyl)phenethyl)benzo[b]thiophene-3-carboxamide

ID: ALA5207986

Chembl Id: CHEMBL5207986

PubChem CID: 168296582

Max Phase: Preclinical

Molecular Formula: C30H28ClNO4S2

Molecular Weight: 566.14

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CCS(=O)(=O)c1ccc(CCN(Cc2cc(Cl)ccc2OCCC)C(=O)c2csc3ccccc23)cc1

Standard InChI:  InChI=1S/C30H28ClNO4S2/c1-3-17-36-28-14-11-24(31)19-23(28)20-32(30(33)27-21-37-29-8-6-5-7-26(27)29)16-15-22-9-12-25(13-10-22)38(34,35)18-4-2/h2,5-14,19,21H,3,15-18,20H2,1H3

Standard InChI Key:  QEJDBDYWAGDSOL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5207986

    ---

Associated Targets(Human)

HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Nlrp3 NACHT, LRR and PYD domains-containing protein 3 (641 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
J774.A1 (2436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nlrc4 NLR family CARD domain-containing protein 4 (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aim2 Interferon-inducible protein AIM2 (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 566.14Molecular Weight (Monoisotopic): 565.1148AlogP: 6.64#Rotatable Bonds: 11
Polar Surface Area: 63.68Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 6.43CX LogD: 6.43
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.19Np Likeness Score: -1.66

References

1. Xu Y, Xu Y, Blevins H, Guo C, Biby S, Wang XY, Wang C, Zhang S..  (2022)  Development of sulfonamide-based NLRP3 inhibitors: Further modifications and optimization through structure-activity relationship studies.,  238  [PMID:35635948] [10.1016/j.ejmech.2022.114468]

Source